Internal Medicine Alert – December 15, 2006
December 15, 2006
View Issues
-
Lung Cancer Screening and the National Debt
Annual CT scanning of at risk people can detect early (Stage 1) lung cancers and perhaps reduce the mortality rate of lung cancer in this group. -
Errors of Omission
A review of ambulatory medical malpractice cases of missed and delayed diagnoses reveals that they result from a witches' brew of multiple breakdowns, cognitive errors, and dysfunctional systems. -
Telbivudine Tablets (Tyzeka™)
The FDA has approved an oral, once-daily drug for the treatment of chronic hepatitis B. Telbivudine is the β-L enantiomer of thymidine with potent antiviral activity against hepatitis B virus. -
Clinical Briefs By Louis Kuritzky, MD
More than three fourths of ischemic stroke survivors experience hemiparesis, with the majority of victims continuing to suffer long term limitations in functional use of their upper extremities. -
ECG Review: What Might Be Wrong?
There are a number of abnormalities apparent in the 12-lead ECG image. First, the rhythm is not sinus, as upright P waves are not seen in lead II. -
Pharmacology Watch
In response to several high-profile drug misadventures including the rofecoxib (Vioxx®) withdrawal from the market, the FDA's Center for Drug Evaluation and Research (CDER) asked the Institute of Medicine (IOM) to assess the drug safety system in the United States.